137 related articles for article (PubMed ID: 9828103)
1. Tissue-specific expression of beta-catenin in normal mesenchyme and uveal melanomas and its effect on invasiveness.
Kim K; Daniels KJ; Hay ED
Exp Cell Res; 1998 Nov; 245(1):79-90. PubMed ID: 9828103
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation translocates beta-catenin from cell-->cell interface to the cytoplasm, but does not significantly enhance the LEF-1-dependent transactivating function.
Kim K; Lee KY
Cell Biol Int; 2001; 25(5):421-7. PubMed ID: 11401329
[TBL] [Abstract][Full Text] [Related]
3. beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition.
Eger A; Stockinger A; Park J; Langkopf E; Mikula M; Gotzmann J; Mikulits W; Beug H; Foisner R
Oncogene; 2004 Apr; 23(15):2672-2680. PubMed ID: 14755243
[TBL] [Abstract][Full Text] [Related]
4. GSK-3beta-dependent phosphorylation of adenomatous polyposis coli gene product can be modulated by beta-catenin and protein phosphatase 2A complexed with Axin.
Ikeda S; Kishida M; Matsuura Y; Usui H; Kikuchi A
Oncogene; 2000 Jan; 19(4):537-45. PubMed ID: 10698523
[TBL] [Abstract][Full Text] [Related]
5. Geldanamycin abrogates ErbB2 association with proteasome-resistant beta-catenin in melanoma cells, increases beta-catenin-E-cadherin association, and decreases beta-catenin-sensitive transcription.
Bonvini P; An WG; Rosolen A; Nguyen P; Trepel J; Garcia de Herreros A; Dunach M; Neckers LM
Cancer Res; 2001 Feb; 61(4):1671-7. PubMed ID: 11245482
[TBL] [Abstract][Full Text] [Related]
6. Activation of beta-catenin in epithelial and mesenchymal hepatoblastomas.
Wei Y; Fabre M; Branchereau S; Gauthier F; Perilongo G; Buendia MA
Oncogene; 2000 Jan; 19(4):498-504. PubMed ID: 10698519
[TBL] [Abstract][Full Text] [Related]
7. Beta-catenin interacts with low-molecular-weight protein tyrosine phosphatase leading to cadherin-mediated cell-cell adhesion increase.
Taddei ML; Chiarugi P; Cirri P; Buricchi F; Fiaschi T; Giannoni E; Talini D; Cozzi G; Formigli L; Raugei G; Ramponi G
Cancer Res; 2002 Nov; 62(22):6489-99. PubMed ID: 12438242
[TBL] [Abstract][Full Text] [Related]
8. Cadherins, catenins and APC in pleural malignant mesothelioma.
Abutaily AS; Collins JE; Roche WR
J Pathol; 2003 Nov; 201(3):355-62. PubMed ID: 14595746
[TBL] [Abstract][Full Text] [Related]
9. Taxol reduces cytosolic E-cadherin and beta-catenin levels in nasopharyngeal carcinoma cell line TW-039: cross-talk between the microtubule- and actin-based cytoskeletons.
Lou PJ; Chen WP; Lin CT; Chen HC; Wu JC
J Cell Biochem; 2000 Sep; 79(4):542-56. PubMed ID: 10996845
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal transition in ovarian cancer progression: a crucial role for the endothelin axis.
Bagnato A; Rosanò L
Cells Tissues Organs; 2007; 185(1-3):85-94. PubMed ID: 17587812
[TBL] [Abstract][Full Text] [Related]
11. KCl cotransporter-3 down-regulates E-cadherin/beta-catenin complex to promote epithelial-mesenchymal transition.
Hsu YM; Chen YF; Chou CY; Tang MJ; Chen JH; Wilkins RJ; Ellory JC; Shen MR
Cancer Res; 2007 Nov; 67(22):11064-73. PubMed ID: 18006853
[TBL] [Abstract][Full Text] [Related]
12. Carnosol inhibits beta-catenin tyrosine phosphorylation and prevents adenoma formation in the C57BL/6J/Min/+ (Min/+) mouse.
Moran AE; Carothers AM; Weyant MJ; Redston M; Bertagnolli MM
Cancer Res; 2005 Feb; 65(3):1097-104. PubMed ID: 15705912
[TBL] [Abstract][Full Text] [Related]
13. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
[TBL] [Abstract][Full Text] [Related]
14. Reduced beta-catenin expression in the cytoplasm of advanced-stage superficial spreading malignant melanoma.
Maelandsmo GM; Holm R; Nesland JM; Fodstad Ø; Flørenes VA
Clin Cancer Res; 2003 Aug; 9(9):3383-8. PubMed ID: 12960126
[TBL] [Abstract][Full Text] [Related]
15. Expression and tyrosine phosphorylation of E-cadherin, beta- and gamma-catenin, and epidermal growth factor receptor in cervical cancer cells.
Moon HS; Choi EA; Park HY; Choi JY; Chung HW; Kim JI; Park WI
Gynecol Oncol; 2001 Jun; 81(3):355-9. PubMed ID: 11371122
[TBL] [Abstract][Full Text] [Related]
16. Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers.
Aust DE; Terdiman JP; Willenbucher RF; Chew K; Ferrell L; Florendo C; Molinaro-Clark A; Baretton GB; Löhrs U; Waldman FM
Mod Pathol; 2001 Jan; 14(1):29-39. PubMed ID: 11211307
[TBL] [Abstract][Full Text] [Related]
17. Turn-off, drop-out: functional state switching of cadherins.
Lilien J; Balsamo J; Arregui C; Xu G
Dev Dyn; 2002 May; 224(1):18-29. PubMed ID: 11984870
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical expression of E-cadherin and beta-catenin in the normal and malignant human endometrium: an inverse correlation between E-cadherin and nuclear beta-catenin expression.
Shih HC; Shiozawa T; Miyamoto T; Kashima H; Feng YZ; Kurai M; Konishi I
Anticancer Res; 2004; 24(6):3843-50. PubMed ID: 15736420
[TBL] [Abstract][Full Text] [Related]
19. Gadd45a regulates matrix metalloproteinases by suppressing DeltaNp63alpha and beta-catenin via p38 MAP kinase and APC complex activation.
Hildesheim J; Belova GI; Tyner SD; Zhou X; Vardanian L; Fornace AJ
Oncogene; 2004 Mar; 23(10):1829-37. PubMed ID: 14647429
[TBL] [Abstract][Full Text] [Related]
20. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes intestinal transdifferentiation in gastric epithelial cells.
Murata-Kamiya N; Kurashima Y; Teishikata Y; Yamahashi Y; Saito Y; Higashi H; Aburatani H; Akiyama T; Peek RM; Azuma T; Hatakeyama M
Oncogene; 2007 Jul; 26(32):4617-26. PubMed ID: 17237808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]